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Although several genetic forms of rare or syndromic hypertriglyceridemia have been reported, little is known about
the specific chromosomal regions across the genome harboring susceptibility genes for common forms of hyper-
triglyceridemia. Therefore, we conducted a genomewide scan for susceptibility genes influencing plasma triglyceride
(TG) levels in a Mexican American population. We used both phenotypic and genotypic data from 418 individuals
distributed across 27 low-income, extended Mexican American families. For the analyses, TG values were log
transformed (ln TG). We used a variance-components technique to conduct multipoint linkage analyses for localizing
susceptibility genes that determine variation in TG levels. We used an ∼10–15–cM map, which was made on the
basis of information from 295 microsatellite markers. After accounting for the effects of sex and sex-specific age
terms, we found significant evidence for linkage (LOD = 3.88) of ln TG levels to a genetic location between the
markers GABRB3 and D15S165 on chromosome 15q. This putative locus explains ( ) of39.7 7% P = .000012
total phenotypic variation in ln TG levels. Suggestive evidence was found for linkage of ln TG levels to two different
locations on chromosome 7, which are ∼85 cM apart from each other. Also, there is some evidence for linkage of
high-density lipoprotein cholesterol concentrations to a genetic location near one of the regions on chromosome
7. In conclusion, we found strong evidence for linkage of ln TG levels to a genetic location on chromosome 15q
in a Mexican American population, which is prone to disease conditions such as type 2 diabetes and the insulin-
resistance syndrome that are associated with hypertriglyceridemia. This putative locus appears to have a major
influence on ln TG variation.
Introduction
The role of hypertriglyceridemia as an independent risk
factor for coronary heart disease (CHD) has been con-
troversial (Gotto 1998). Recently, however, increasingly
strong evidence for its role as a CHD risk factor has
emerged (Austin et al. 1998; Havel 1998; Jeppesen et
al. 1998). Although fasting plasma triglyceride (TG) lev-
els 1200 mg/dl have been considered to increase risk,
recent evidence suggests that an even lower threshold
(1100 mg/dl) could be deleterious in patients with es-
tablished coronary artery disease (Miller et al. 1998).
Hypertriglyceridemia is commonly found in individuals
with type 2 diabetes, and it is an element of the so-called
metabolic syndrome (Ginsberg 1996; Howard 1996;
Garg 1998; Grundy 1998). People with type 2 diabetes
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and those who are prediabetic have a greater risk of
CHD than do individuals who are unaffected (Haffner
et al. 1990; Hsueh and Law 1998).
Since the molecular basis of CHD is incompletely
understood, there have been continued efforts to dis-
entangle the genetic architecture of CHD risk factors,
including fasting plasma TG levels. Numerous genetic
epidemiological studies have demonstrated that the var-
iation in TG levels is affected by both genetic and en-
vironmental factors (Iselius 1988; Rice et al. 1991;
Mitchell et al. 1996). A few studies have examined ma-
jor locus effects on TG concentrations by making use
of segregation analysis, but the results have been in-
conclusive (Singh et al. 1988; MacCluer 1989). Several
forms of hypertriglyceridemia, such as chylomicro-
nemia, familial hypertriglyceridemia, and familial com-
bined hyperlipidemia, are attributable to genetic ab-
normalities (Grundy 1998). Recently, a susceptibility
locus for familial combined hyperlipidemia has been
localized to a genetic location on chromosome 1q21-
q23 (Pajukanta et al. 1998). Also, the gene for Tangier
disease, which is associated with increased levels of TGs,
has been assigned to chromosome 9q31 (Rust et al.
1998). However, little is known about the specific major
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Table 1
Distribution of Relative Pairs by Category in a Subset of 27
SAFADS Families Containing 418 Individuals
Relative Pair
Relationship
Coefficienta
No. of
Pairs
Parent-offspring .5000 396
Sibs .5000 491
Grandparent-grandchild .2500 100
Avuncular .2500 633
Half-sibs .2500 65
Great-grandparent–grandchild .1250 12
Grand avuncular .1250 124
Half-avuncular .1250 66
First cousins .1250 656
Great-grandavuncular .0625 3
Half-grandavuncular .0625 11
First cousins, once removed .0625 479
Half–first cousins .0625 75
First cousins, twice removed .0312 9
Half–first cousins, once removed .0312 32
Second cousins .0312 212
Second cousins, once removed .0156 15
Total 3,379
a The relationship coefficient is 2 # coefficient of kinship of two
individuals.
genetic determinants of common forms of hypertri-
glyceridemia.
In this study, we scanned the genome for susceptibility
loci influencing the plasma TG levels by making use of
pedigree data from a low-income Mexican American
population. In Mexican Americans, the prevalence of
type 2 diabetes is three times higher than in the general
U.S. population (Stern andHaffner 1990). Furthermore,
Mexican Americans without diabetes have been shown
to be more insulin resistant than members of the non-
Hispanic white population (Haffner et al. 1986, 1990).
Our genomewide scan for loci affecting plasma TG
levels used a multipoint variance-components linkage
approach and an ∼10–15–cM map.
Material and Methods
The San Antonio Family Diabetes Study (SAFADS) aims
to identify susceptibility genes for type 2 diabetes and
related phenotypes by use of data from extended pedi-
grees (Stern et al. 1996; Duggirala et al. 1996, 1999).
A total of 579 individuals (140 with diabetes) in 32
families ascertained on a type 2 diabetic proband were
examined, involving first-, second-, and third-degree
relatives aged 18–98 years. Metabolic, anthropometric,
demographic, and medical history information were ob-
tained on all the examined individuals. A subset of 440
individuals (116 with diabetes) from the 27 largest ped-
igrees were selected for genotyping. All procedures were
approved by the Institutional Review Board of the Uni-
versity of Texas Health Science Center at San Antonio,
and all subjects gave informed consent.
Blood samples were obtained after a 12-h fast. The
blood was assessed for various metabolic traits, includ-
ing glucose, TG, and high-density lipoprotein choles-
terol (HDL-C) concentrations, by methods described
elsewhere (Stern et al. 1984). Duplicate measures for a
given trait were used to assess the extent of measure-
ment error. The technical error of measurement for
HDL-C was 1.1% of the mean; for TG, it was 1.2%.
Of the 440 SAFADS subjects, TG values were available
for 422 individuals. TG values 1800 mg/dl were ex-
cluded from the analysis because they were distinct out-
liers (i.e., only four individuals). For the present anal-
ysis, which is based on phenotypic information from
418 individuals, the TG values were log transformed
(ln TG). These 418 individuals generated 3,379 relative
pairs that were distributed across 17 categories of rel-
ative pairs (e.g., sibs, first cousins, second cousins, etc.),
as shown in table 1. Glucose levels were also measured
2 h after a standardized oral glucose load. Diabetes was
diagnosed according to criteria of the World Health
Organization (1985).
Genotyping
A set of 295 markers was used for the multipoint
linkage analysis, which provided coverage at intervals
of ∼10–15 cM on chromosomes 1–22 (Duggirala et al.
1999). Primers were purchased from Research Genetics.
Further details concerning oligonucleotide primer se-
quences and polymorphisms can be obtained from the
Genome Data Base at Johns Hopkins University (Fas-
man et al. 1996). PCR conditions were optimized by
testing a range of annealing temperatures with varying
concentrations of MgCl2 so that the PCR amplification
produced a specific product that could be visualized by
ethidium bromide staining (0.5 mg/ml).
Genotypes were collected primarily by PCR assays
with radiolabeled oligonucleotide primers. The antisense
primer was 5′-radiolabeled in a standard polynucleotide
kinase reaction by 3,000 Ci/mmol [g32P]-adenosine tri-
phosphate (ATP; from NEN) at a molar ratio of 18
[g32P]-ATP:1 primer, as described elsewhere (O’Connell
et al. 1994; Duggirala et al. 1996). Thirty cycles of PCR
(denaturing at 94C for 30 s, annealing at 55C for 1
min, and extension at 72C for 1 min) were done in a
15-ml assay containing 50 ng of DNA template, 10 mM
Tris-HCl, pH 8.3, 50 mM KCl, 1–4 mM MgCl2, 0.1 M
spermidine (Sigma), 0.1 mM of each PCR primer, 0.1
mM dNTPs (Gibco BRL), and 0.5 U of Taq polymerase
(PE Biosystems). Amplified DNA was diluted 1:1 with
stop solution (97% formamide, 1% EDTA, 0.1% bro-
mophenol blue, and 0.1% xylene cyanol) and denatured
at 85C for 2 min. Three microliters of denatured DNA
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from each sample were loaded onto a 7% denaturing
polyacrylamide gel (19:1 acrylamide/bis-acrylamide)
containing 32% formamide and 34% urea and frac-
tionated by gel electrophoresis for 2.5 h at 60 W. Gels
were transferred to filter paper (Whatman 3MM; from
W. R. Balston) covered with plastic wrap, equilibrated
with 20% methanol–20% acetic acid solution, and
dried. Dried gels were exposed to X-ray film (Fuji Photo
Film). As reported elsewhere (Duggirala et al. 1999),
data for some of the markers were collected by means
of fluorescent-labeled primers, purchased from Research
Genetics. These were PCR amplified, as described above,
and were loaded onto an Applied Biosystems model 373
sequencer, and the data were analyzed by Applied Bio-
systems GENOTYPER software.
The genotypic data used for this study were analyzed
for discrepancies (i.e., violations of Mendelian inheri-
tance) by the program INFER (Dyke 1996). Before con-
ducting linkage analyses, the SAFADS pedigree struc-
tures were verified with information from ∼50 poly-
morphic loci, including red blood cell antigens. The dis-
crepancies were checked for mistyping in the laboratory,
and a few instances that could not be resolved were
presumed to be due to factors such as sample mix-up,
nonparentage, or mutations. These unresolved cases
were treated as missing data. Pedigree information was
rechecked with family members, and blood sampleswere
redrawn from relevant individuals whenever possible.
Checking and rechecking the pedigree resulted in eight
discrete pedigree revisions.
The genotypic information for SAFADS participants
was routinely verified, and discrepancies were checked
in the laboratory for mistyping. Markers for discrepant
individuals were either corrected or blanked out prior
to analysis. The average percentage of genotypes
blanked (i.e., the number of genotypes blanked divided
by the total number of genotypes) is ∼.06%. Thus far,
1400 markers have been typed, and all markers were
used for two-point linkage analysis. Since ourmultipoint
linkage approach yields optimum results when similar
numbers of individuals are genotyped at all loci, markers
with !80% of the sample genotyped were not considered
for multipoint analysis unless their absence would result
in a map gap of 20 cM (Duggirala et al. 1999). This
arbitrary requirement excluded ∼25% of the markers.
Thus, the multipoint analyses are made on the basis of
a total of 295 markers. In addition, ∼4% of the total
SAFADS marker data set could not be used for the mul-
tipoint analyses because of genotyping problems (i.e.,
markers failed to map to their expected positions or led
to map expansion).
Statistical Genetic Analysis
We used a variance-components approach to test for
linkage of a genetic location with ln TG levels by means
of maximum-likelihood methods (Amos 1994; Blangero
and Almasy 1997; Almasy and Blangero 1998). The var-
iance-components method uses information from all
possible biological relationships simultaneously in an at-
tempt to disentangle the genetic architecture of a quan-
titative trait. This method specifies the expected genetic
covariances between relatives as a function of their iden-
tity-by-descent (IBD) relationships at a marker locus
(which is hypothesized to be linked to a locus influencing
the quantitative trait [QTL]). It allows for locus-specific
effects (h2q is heritability attributed to the QTL), residual
additive genetic effects (h2 is heritability attributed to the
residual genetic effects), covariate effects (e.g., age and
sex), and individual-specific random environmental fac-
tors [ ].2 2 2e = 1–(h  h )q
In this study, in addition to the variance components,
mean and SD of the phenotype and covariate effects (i.e.,
sex-specific age, and age2 and sex terms) were simulta-
neously estimated by maximum-likelihood techniques.
Hypothesis testing was performed by the likelihood ratio
tests. The hypothesis of no linkage (i.e., additive genetic
variance due to the ) was tested by comparingQTL = 0
the likelihood of this restricted model with that of a
model in which the additive genetic variance due to
the QTL is estimated. Twice the difference in ln likeli-
hoods of these two models yields a test statistic that is
asymptotically distributed as a ½:½ mixture of a and2x1
a point mass at zero (Self and Liang 1987). LOD scores
were obtained by converting the ln likelihood values into
values of log10. After obtaining locus-specific IBD infor-
mation for pairs of relatives by the computer program
SOLAR (Almasy and Blangero 1998), the multipoint
mapping strategy proposed by Fulker et al. (1995) was
extended and modified (Almasy and Blangero 1998) to
perform multipoint variance-components linkage anal-
ysis. These procedures were implemented in the SOLAR
program.
Results
The characteristics of the subjects used for this study are
reported in table 2. All genetic analyses included sex and
sex-specific age and age2 terms as covariates of ln TG
values. After accounting for the significant covariate
effects, the overall polygenic heritability (h2) for ln
TG values was estimated to be , with high33.6 9%
statistical significance ( ). The covariates ex-P ! .0001
plained ∼14% of total phenotypic variation in ln TG.
Following this, the multipoint linkage analysis was con-
ducted, and the results of our genome scan (i.e., peak
LOD score by chromosome) are summarized in figure
1. All LOD scores reported below relate to multipoint
analysis, and only multipoint LOD scores near 2 or
above are discussed.
The highest LOD score that we observed was 3.88,
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Table 2
Characteristics of SAFADS Subjects Distributed
across 27 Families Included in the Genotyping
Set
Variable Mean  SD or %
Age at examination (years) 43.3  17.3
Men 41.2%
Women 58.8%
Diabetics 26.4%
Body mass index (kg/m2) 30.0  6.7a
TGs (mg/dl) 173.6  109.2b
ln TGs 5.0  .6c
HDL-C (mg/dl) 38.0  10.2d
a Subjects with diabetes, ; subjects31.9 6.6
without diabetes, .29.4 6.6
b Subjects with diabetes, ; sub-212.4 116.4
jects without diabetes, .160.3 103.5
c Subjects with diabetes, ; subjects5.2 .5
without diabetes, .4.9 .5
d Subjects with diabetes, ; subjects37.9 11.0
without diabetes, .38.0 9.9
Figure 1 Summary of the multipoint linkage analyses of ln TG:
peak multipoint LOD score by chromosome.
which is highly statistically significant and corresponds
to a susceptibility locus for ln TG on chromosome 15q
between the markers GABRB3 (gamma-aminobutyric
acid A receptor, beta-3) and D15S165 (fig. 2). The mul-
tipoint LOD scores obtained for ln TG were plotted
against map positions on chromosome 15 (fig. 2). As
can be seen from this figure, the markers GABRB3 and
D15S165 cover a region of ∼10 cM, which appears
to harbor a major susceptibility locus for hypertri-
glyceridemia. The heritability attributable to this pu-
tative locus (h2q) was estimated to be (39.7 7% P =
). Although the QTL heritability (h2q) is greater.000012
than the overall polygenic heritability (h2), it is within
the estimated SE around the overall polygenic herita-
bility (i.e., ). Also, since the polygenic2h = 33.6 9%
model was rejected in favor of the model including the
QTL effect, the latter gives a more unbiased estimate
of the heritability.
Two regions on chromosome 7 are suggestively linked
(i.e., a multipoint LOD score near 2 or above) to ln TG
levels: a genetic location between markers D7S506 and
D7S653 (LOD 2.05) and a location between markers
D7S1824 and D7S688 (LOD 1.86). This is shown in
figure 3. The former peak is relatively broad and covers
a region of ∼11 cM between the sequential markers
D7S506 and D7S653. The two suggestive susceptibility
loci on chromosome 7 are ∼85 cM apart from each
other. No other multipoint LOD scores near 2 or above
were observed in our genomewide scan. Given the
known correlation between TGs and HDL-C, only one
of the three chromosomal regions of interest for ln TGs
in this study appears to be also linked with HDL-C
levels—namely, the region near marker D7S479 (i.e.,
between markers D7S653 and D7S479) on chromo-
some 7 (fig. 3). Although the LOD curves peak at dif-
ferent locations for these phenotypes (ln TGs at 94 cM
and HDL-C at 117 cM), the trait-specific linkage curves
exhibit appreciable overlapping. The region on chro-
mosome 15q, however, failed to show any evidence for
linkage to HDL-C (LOD score = 0).
We conducted two independent analyses after our
original findings were concluded to verify whether our
results were sensitive to ascertainment bias or to the
diabetic status of the subjects. Since the SAFADS fam-
ilies were ascertained on type 2 diabetic probands, we
reran the analysis, as a conservative approach, by cor-
recting for the ascertainment by conditioning on like-
lihood of observing the ln TG of the proband with di-
abetes. We also reran the analysis after accounting for
the effect of type 2 diabetes on ln TG values. However,
the differences between the three analyses were trivial.
Discussion
Hypertriglyceridemia is an important component of the
risks associated with CHD, type 2 diabetes, and the met-
abolic syndrome. Increased concentrations of TG are
associated with several types of dyslipidemias. Fasting
plasma TG levels are surrogates for TG-rich lipoproteins
(e.g., chylomicrons and very-low-density lipoproteins;
Grundy 1998). Hypertriglyceridemia often correlates
with hyperinsulinemia in the general population (Steiner
and Lewis 1996) and is associated with increased con-
centrations of small, dense, low-density lipoproteins
(Mykka¨nen et al. 1997).
A number of studies have examined population as-
sociations between various candidate genes related to
lipoprotein metabolism and plasma TG levels. For ex-
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Figure 2 Linkage of ln TG to a quantitative trait locus between
markers GABRB3 and D15S165 on chromosome 15.
Figure 3 Plot of LOD scores obtained for ln TG and HDL-C
concentrations against map positions on chromosome 7.
ample, studies have shown associations between vari-
ation in or near the lipoprotein lipase (LPL) gene (chro-
mosome 8p22) and plasma TG levels (Gerdes et al.
1995; Humphries et al. 1998). Also, TG levels have been
shown to be correlated with variants in the promotor
region of the LPL gene (Ehrenborg et al. 1997; Wittrup
et al. 1997; Talmud et al. 1998). Recently, a meta-anal-
ysis was conducted to assess the effect of various mu-
tations at the LPL locus (i.e., Gly188Glu, Asp9Asn,
Asn291Ser, and Ser447Ter substitutions) in the hetero-
zygous state on lipid metabolism and risk of ischemic
heart disease in whites (Wittrup et al. 1999). Individuals
who carry the Gly188Glu, Asp9Asn, and Asn291Ser
substitutions, compared with individuals who do not
carry these substitutions, were shown to have an ath-
erogenic lipoprotein profile, whereas individuals who
carry the Ser447Ter substitution were found to have a
protective lipoprotein profile. There is evidence for an
association between TG levels and variation in the APO
CIII (apolipoprotein CIII) gene (chromosome 11q23) or
in its promotor (Zeng et al. 1995; Surguchov et al. 1996;
Hegele et al. 1997). Our failure to find linkage in genetic
regions containing loci such as the LPL and the APO
CIII in Mexican Americans may be due to the possible
heterogeneity of common forms of hypertriglyceridemia
across the populations.
Population association studies have limitations at-
tributable to problems such as misclassification and
population stratification, and they are more likely to
generate false-positive results (Khoury et al. 1993).
Also, it is usually not possible to evaluate the magnitude
of the genetic effects exerted by such loci on the basis
of association analysis; linkage approaches, on the other
hand, that make use of data gathered from members of
families can be helpful in determining the magnitude of
genetic effects (Cox and Bell 1989). Recently, bymaking
use of linkage analysis, susceptibility genes for familial
combined hyperlipidemia (Pajukanta et al. 1998) and
Tangier disease (Rust et al. 1998), which are associated
with elevated TG levels, have been localized. However,
our failure to find evidence for linkage in regions cor-
responding to familial combined hyperlipidemia and
Tangier disease may be related to their distinct etiolo-
gies, which could play a minor role in determining var-
iation in TG levels in Mexican Americans.
Knowledge of the major determinants of common
forms of hypertriglyceridemia in humans is limited. We
conducted a genomewide search for susceptibility genes
influencing ln TG levels in a Mexican American pop-
ulation by using pedigree data and a variance-compo-
nents linkage approach; we found significant evidence
for a major susceptibility locus influencing TG con-
centrations on chromosome 15q between markers
GABRB3 (15q11.2) and D15S165 (15q12-q13.1). Sev-
eral criteria have been proposed to verify a claim of
significant linkage at the level of a genomewide scan
(Lander and Kruglyak 1995; Elston 1998; Morton
1998). For example, in reference to the allele-sharing
methods, such as the one used in this study, Lander and
Kruglyak (1995), by making use of simulations, pro-
posed the term “significant linkage” to refer to LOD
scores for various types of relative pairs in the range of
∼3.3–3.8. Following this suggestion, the observed mul-
tipoint LOD of 3.88 at this location on chromosome
15q corresponds to a significant linkage.
Since a multivariate normal distribution is assumed
in our linkage approach, there may be some concerns
about violations of this assumption (Elston 1998; Al-
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lison et al. 1999). Although the variance-component
approach has been shown to be robust to such viola-
tions (Beaty et al. 1985; Amos 1994), recently, sib-
pair–based data simulations have shown that some
types of nonnormality (e.g., leptokurtosis) can lead to
inflated type I error rates and that the degree of such
an inflation rate seems to be directly related to the re-
sidual sib correlation (Allison et al. 1999). In this con-
nection, the significance of the present finding is less
likely to be spuriously inflated for the following reasons.
After accounting for the effects of covariates on ln TG
levels, the violation of nonnormality of the residuals
used in this study appears, on the basis of the coefficients
for skewness (.37) and kurtosis (.02), to be minor. Also,
the extent of proportion of variance explained by the
major QTL in our study implies the low residual sibling
correlation.
There are no obvious candidate genes for hyper-
triglyceridemia in this region of chromosome 15q, al-
though it is worth noting that the Prader-Willi syndrome
(MIM 176270) and the Angelman syndrome (MIM
105830) map to the chromosomal region 15q11-13,
which is close to the area of interest in our study. The
hepatic lipase (HL) gene (MIM 151670), which has a
role in TG metabolism, has been localized to chromo-
somal region 15q21-23 (Sparkes et al. 1987). The HL
gene is located ∼25–30 cM centromeric to the genetic
location (i.e., peak) of interest in the present study.
However, given our recent finding, in another set of
Mexican American families, of significant linkage be-
tween a genetic location near the HL gene and a com-
ponent of HDL-C—namely, unesterified HDL2a-C (Al-
masy et al. 1999)—we are planning to screen the HL
gene to assess its relation to the present finding.
Two different locations on chromosome 7 are sug-
gestively linked to susceptibility loci influencing ln TG
levels. The first susceptibility locus (LOD 2.05) is be-
tween markers D7S506 and D7S653. A candidate gene
close to marker D7S653 is the collagen and thrombos-
pondin receptor CD36 (MIM 173510), which maps to
7q11.2 (Ferna´ndez-Ruiz et al. 1993). Recently, Aitman
et al. (1999) identified CD36 as an insulin-resistance
gene that underlies defective fatty acid metabolism and
hypertriglyceridemia in the spontaneously hypertensive
rat. These authors suggested a possible role for CD36
in the etiology of the insulin-resistance syndrome in hu-
mans. Earlier, in a sibship-based analysis, we reported
evidence for linkage of insulin precursors (intact and
32,33 split proinsulin) to a genetic location near marker
D7S479 on 7q (Duggirala et al. 1996), which is ∼16
cM telomeric to the region of interest (i.e., the region
between markers D7S506 and D7S653) in the present
study. As discussed earlier, there is some evidence for
linkage of HDL-C levels to a genetic location near
marker D7D479, and the LOD curves for both ln TG
and HDL-C exhibit appreciable overlap, suggesting the
possibility that a locus is influencing both phenotypes.
Other genes of interest in this region of 7q are paraox-
onase genes and plasminogen activator inhibitor 1
(Klinger et al. 1987; Mochizuki et al. 1998; Sanghera
et al. 1998). Recently, we have found strong evidence
for linkage (LOD 3.6) of HDL-C levels to a region on
chromosome 9p near markers D9S925 and D9S1121
(Arya et al. 1999), although this region failed to show
evidence for linkage to ln TG. These findings are con-
sistent with those of an earlier study involving the Mex-
ican American population—that TG and HDL-C con-
centrations are influenced by both shared genes and that
each of these phenotypes appears to be influenced in-
dependently by unshared genes as well (Mahaney et al.
1995).
The second susceptibility locus on chromosome 7q
for ln TG is near marker D7S688. In a previous sibship-
based analysis, we found evidence for a susceptibility
locus for various obesity-related traits, which is linked
to a genetic location near marker D7S495 (i.e., between
markers D7S495 and D7S688) on chromosome 7q
(Duggirala et al. 1996). It is possible that our earlier
and present results may be related to the same suscep-
tibility locus. Given the known association between
pancreatitis and TG levels, it is interesting to note that
the gene for hereditary pancreatitis (MIM 167800)
maps to chromosome 7q35 (Whitcomb et al. 1996;
Gorry et al. 1997). The chromosomal region between
markers D7S495 and D7S688 has been shown to en-
compass the hereditary pancreatitis locus (Pandya et al.
1996). Our second susceptibility locus on chromosome
7 lies in the same region, and it is 2 cM centromeric to
marker D7S688.
In conclusion, on the basis of a genomewide scan, we
found evidence for a major susceptibility locus on chro-
mosome 15q influencing ln TG levels in a Mexican
American population. This putative locus appears to
have substantial influence on the phenotypic variation
in ln TG levels. Also, two other susceptibility loci on
chromosome 7 appear to have minor influences on var-
iation in ln TG levels. One of these two loci on chro-
mosome 7 may have a common influence on both ln
TG and HDL-C. These findings may be unique to the
Mexican Americans, a population prone to diseases
such as obesity, insulin-resistance syndrome, and type
2 diabetes. However, as noted earlier, the findings ap-
pear not to be influenced by the diabetic condition.
Given the possibility of heterogeneity across popula-
tions, generalization of our observations would require
evidence for influence of the same loci on variation in
TG levels in other populations. For precise localization
of these susceptibility loci, especially the one on chro-
mosome 15q, we plan to conduct fine-structure map-
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ping with single nucleotide polymorphisms and linkage
disequilibrium mapping techniques.
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